Reuters logo
BRIEF-Dynavax says PDUFA date for HEPLISAV-B remains unchanged
April 3, 2017 / 10:08 AM / 6 months ago

BRIEF-Dynavax says PDUFA date for HEPLISAV-B remains unchanged

April 3 (Reuters) - Dynavax Technologies Corp:

* Dynavax announces FDA advisory committee meeting to review HEPLISAV-B

* Dynavax Technologies Corp - PDUFA date for HEPLISAV-B remains unchanged

* Dynavax -U.S. FDA informed co that VRBPAC will review HEPLISAV-B, hepatitis b vaccine, recombinant (adjuvanted)] at its meeting scheduled for July 28, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below